Tarsus Pharmaceuticals files initial ownership statement for Neera Clase
TARS•Chief Commercial Officer Neera Clase disclosed direct ownership of 14,800 Tarsus Pharmaceuticals common shares in an initial beneficial ownership statement.
1. Ownership disclosure
Chief Commercial Officer Neera Clase disclosed direct ownership of 14,800 Tarsus Pharmaceuticals common shares in an initial beneficial ownership statement.
